News Search Results
Jan 08, 2026, 03:00 ET Nearly 90 Physicians from MemorialCare's Long Beach Medical Center, Miller Children's & Women's Hospital Recognized by Leading Doctor's Report
Oncology, Infectious Disease, Maternal/Fetal Medicine, Neonatal/Perinatal Medicine, Neurology, Neurological Surgery, Obstetrics/Gynecology, Oncology, Ophthalmology, Orthopaedic Surgery, Pediatric Surgery, Pediatrics, Plastic Surgery, Pulmonary Medicine, Radiology, Rheumatology, Sleep Medicine, Surgery, General,
More news about: MemorialCare Long Beach Medical Center and Miller Children's & Women's Hospital
Jan 07, 2026, 11:56 ET CooperVision wprowadza na rynek jednodniowe miękkie soczewki kontaktowe MyDay® MiSight® 1 day do kontroli krótkowzroczności
temporal trends from 2000 through 2050 (Występowanie krótkowzroczności i wysokiej krótkowzroczności na świecie, tendencje czasowe w latach 2000-2050). Ophthalmology. 2016;123(5):1036-1042E. L. Lamoureux i in. Myopia and Quality of Life: The Singapore Malay Eye Study (SiMES) (Krótkowzroczność a jakość
More news about: CooperVision, Inc.
Jan 07, 2026, 10:03 ET AMSURG Centers Earn National Recognition in 2025 Press Ganey Human Experience Awards
health systems, the organization delivers high-quality patient care across a diverse spectrum of medical specialties, including gastroenterology, ophthalmology and orthopedics. Guided by its core values — Care Deeply, Champion Excellence, Cultivate Integrity and Celebrate Teamwork — AMSURG is committed
More news about: AMSURG Corporation
Jan 07, 2026, 08:08 ET Ascend Vision Partners Enters Oklahoma Market with the Acquisition of 3 Leading Ophthalmology Practices
premier retinal specialty practice providing advanced medical and surgical retina careWise Eye Associates, offering comprehensive ophthalmology services with a long-standing reputation for clinical excellenceSylvester Eye Care & Aesthetics, delivering integrated eye care
More news about: Ascend Vision Partners
Jan 06, 2026, 18:42 ET Celltrion to present at the 44th Annual J.P. Morgan Healthcare Conference
monoclonal antibody biosimilar. Our global pharmaceutical portfolio addresses a range of therapeutic areas including immunology, oncology, hematology, ophthalmology and endocrinology. Built on trust through our fully integrated capabilities – from advanced R&D and in-house manufacturing to a reliable global
More news about: Celltrion
Jan 06, 2026, 18:30 ET Astellas to Present at 44th Annual J.P. Morgan Healthcare Conference
company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases
More news about: Astellas Pharma Inc.
Jan 06, 2026, 12:15 ET CooperVision bringt weiche MyDay® MiSight® 1 day Kontaktlinsen zur Myopie-Kontrolle auf den Markt
Datei, 2025.Holden BA, Fricke TR, Wilson DA, et al. Globale Prävalenz von Myopie und hoher Myopie und zeitliche Trends von 2000 bis 2050. Ophthalmology. 2016;123(5):1036-1042E. L. Lamoureux et al. Myopia and Quality of Life: Die Singapore Malay Eye Study (SiMES). IOVS 2008;49(13):4469.Chua
More news about: CooperVision, Inc.
Jan 06, 2026, 11:00 ET VivaVision Biotech Receives Positive Written Feedback from FDA - VVN461HD New Drug Application (NDA) Requires Only a "Single Phase III" Pivotal Clinical Study in the U.S. for Non-Infectious Anterior Uveitis Treatment
efficacy, reflecting the clinical development and execution capabilities of the VivaVision team. We look forward to achieving more breakthroughs with ophthalmology drugs represented by VVN461HD in the future. At the same time, we are very grateful for the FDA's recognition of the Phase II clinical trial of
More news about: VivaVision Biotech
Jan 06, 2026, 10:56 ET Společnost CooperVision uvede na trh měkké kontaktní čočky MyDay® MiSight® 1 day pro kontrolu krátkozrakosti
archivu, 2025Holden BA, Fricke TR, Wilson DA, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036-1042E. L. Lamoureux et al. Myopia and Quality of Life: The Singapore Malay Eye Study (SiMES). IOVS 2008;49(13):4469.Chua
More news about: CooperVision, Inc.
Jan 06, 2026, 08:28 ET CooperVision lanzará las lentes de contacto blandas MyDay® MiSight® de 1 día para el control de la miopía
file, 2025Holden BA, Fricke TR, Wilson DA, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036-1042E. L. Lamoureux et al. Myopia and Quality of Life: The Singapore Malay Eye Study (SiMES). IOVS 2008;49(13):4469.Chua
More news about: CooperVision, Inc.
Jan 06, 2026, 08:00 ET CooperVision to Launch MyDay® MiSight® 1 day Myopia Control Soft Contact Lenses
file, 2025Holden BA, Fricke TR, Wilson DA, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036-1042E. L. Lamoureux et al. Myopia and Quality of Life: The Singapore Malay Eye Study (SiMES). IOVS 2008;49(13):4469.Chua
More news about: CooperVision, Inc.
Jan 05, 2026, 18:55 ET Everest Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference
Medicines has built a portfolio of potentially global first-in-class or best-in-class molecules in the company's core therapeutic areas of autoimmune, ophthalmology, critical care, and CKM (cardiovascular, kidney, and metabolic). For more information, please visit its website at
More news about: Everest Medicines
Dec 30, 2025, 13:54 ET Parker Waichman LLP Files Lawsuit on behalf of Philadelphia Resident Alleging Development of Irreversible Eye Condition, NAION, after taking Ozempic
concerns about the failure of drug manufacturers to warn consumers and medical professionals about these risks.A 2025 study published in JAMA Ophthalmology examined nine patients who developed optic nerve disorders after using GLP-1 medications, with the majority suffering from
More news about: Parker Waichman LLP
Dec 29, 2025, 09:00 ET Costa Rica Strengthens Its Global Leadership in Medical Devices, Exporting Innovation to the World
Ireland, Sweden, Japan, Spain and other markets operate in the country, covering specialized areas such as endoscopy, cardiology, orthopedics, ophthalmology, diagnostics and advanced surgical solutions.This performance reflects Costa Rica's transition toward an economy driven by innovation, advanced
More news about: PROCOMER
Dec 29, 2025, 09:00 ET Costa Rica Strengthens Its Global Leadership in Medical Devices, Exporting Innovation to the World
Ireland, Sweden, Japan, Spain and other markets operate in the country, covering specialized areas such as endoscopy, cardiology, orthopedics, ophthalmology, diagnostics and advanced surgical solutions.This performance reflects Costa Rica's transition toward an economy driven by innovation, advanced
More news about: PROCOMER
Dec 25, 2025, 03:45 ET China's First Domestic Anti-CTLA-4 Monoclonal Antibody, Innovent's TABOSUN® (Ipilimumab N01 Injection) Received NMPA Approval
that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announces that the New Drug Application (NDA) for TABOSUN® (ipilimumab N01 injection; R&D Code: IBI310),
More news about: Innovent Biologics
Dec 23, 2025, 15:15 ET Prevent Blindness Joins January's National Glaucoma Awareness Month Efforts to Combat the "Silent Thief of Sight"
Allison MD, MBA, FACS, Associate Professor of Clinical Ophthalmology, Flaum Eye Institute, University of Rochester Medical Center, and Prevent Blindness Board of Directors member, and Pathik P. Amin, OD, FAAO, Visiting Associate Professor of Ophthalmology, Glaucoma Service, Illinois Eye and Ear Infirmary,
More news about: Prevent Blindness
Dec 23, 2025, 09:23 ET Zydus Partners with Bioeq for U.S. Commercialisation rights for NUFYMCO®, an Interchangeable Biosimilar to Lucentis®
combined expertise and resources to accelerate organisational growth while ensuring maximum value to patients through an expanded access to affordable ophthalmology care."Dr. Thiemo Schreiber, Vice President Commercial at Bioeq, stated, "We are excited about the regulatory approval of "NUFYMCO®
More news about: Zydus Lifesciences
Dec 17, 2025, 08:30 ET Navigate Patient Solutions and Glacial Multimedia Announce Exclusive Marketing Partnership to Accelerate Practice Growth for Cataract Surgeons
That Works for Surgeons — and Their PatientsNavigate's vision is to create the first truly integrated patient-education platform in ophthalmology — one that helps surgeons activate interest, educate patients with clarity, and motivate them to choose the vision they want.By adding
More news about: Navigate Patient Solutions
Dec 17, 2025, 06:45 ET PADCEV™ Plus Keytruda® Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility
company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases
More news about: Astellas Pharma Inc.
Dec 16, 2025, 13:53 ET The Surgery Center of Rhode Island Recognized as Leapfrog Top Ambulatory Surgery Center for Third Consecutive Year
Island, SCRI opened in 2008 through a partnership with Constitution Surgery Alliance (CSA) and 35 surgeons specializing in ear, nose, throat, and ophthalmology procedures. Since then, SCRI has built a reputation for world-class outpatient surgical care in a state-of-the-art environment."Receiving
More news about: Constitution Surgery Alliance
Dec 16, 2025, 08:30 ET East Bay Surgery Center Named a Leapfrog "Top Ambulatory Surgery Center" for 2025
patient satisfaction metrics.Notably, EBSC was also named among U.S. News & World Report's "Best Ambulatory Surgery Centers" for ophthalmology in both 2024 and 2025, further cementing its reputation as a regional and national leader in outpatient surgical care.EBSC opened in 2005
More news about: Constitution Surgery Alliance
Dec 16, 2025, 08:30 ET 5 Hartford HealthCare ambulatory surgery centers recognized nationally with Leapfrog award
ASCs are part of a network providing access to outpatient surgical care in orthopedics, total joint replacement, spine surgery pain management and ophthalmology. CSA, a leading developer and operator of outpatient surgery centers, is the managing partner of the ASCs."Achievements like this inspire
More news about: Constitution Surgery Alliance
Dec 16, 2025, 06:03 ET HelpMeSee Welcomes Renowned Ophthalmologist Dr. Jack Cioffi to Its Board of Directors
Chair of the Department of Ophthalmology at Columbia University Irving Medical Center, and Ophthalmologist-in-Chief at New York-Presbyterian Hospital/Columbia. He previously held leadership roles as Director of the Devers Eye Institute and Chair of the Department of Ophthalmology & Chief Medical Officer
More news about: HelpMeSee
Dec 15, 2025, 09:10 ET The Leapfrog Group Announces 2025 Top Hospitals and Top ASCs
2025 Top ASC Award. ASCs in nine surgical specialties are represented:gastroenterology,general surgery,ophthalmology,otolaryngology,orthopedic surgery,urology,neurological surgery,obstetrics and gynecology, andplastic
More news about: The Leapfrog Group